French regulators provide guidance to prevent confusion between medicines and food supplements

Eveline Van Keymeulen

Earlier this summer, the French National Agency for Medicines and Health Products Safety (ANSM) and the French National Agency for Food, Environmental and Occupational Health & Safety (ANSES) published recommendations to help healthcare professionals and patients distinguish medicines from food supplements. The recommendations follow pharmacy reports about a risk of confusion between the medicinal product Read More

French Supreme Court confirms discriminatory abuse in market of medical information databases for pharmaceutical companies

Florence Ninane

Earlier this summer, the French Supreme Court (Cour de Cassation) rejected an appeal by Cegedim against a ruling of the Paris Court of Appeal, upholding a July 2014 decision of the French Competition Authority (FCA) that imposed a EUR 5.7 million fine on the company. The FCA had found that Cegedim’s refusal to grant a Read More

ANSM launches public consultation on advertising of medicinal products to public

Audrey Aboukrat

The French medicines regulator (ANSM) recently launched a public consultation concerning the warning message that pharmaceutical companies must include in all audio-visual advertising of medicinal products to the public, as part of the mandatory information required for medicine advertising by Articles L. 5122-6 and R. 5122-3 of the French Public Health Code.  The consultation concerns Read More

Majority of invented names for medicinal products rejected

Eveline Van Keymeulen

In 2016, more than half of the proposed invented names for centralised medicinal products were rejected (246 rejections to 241 acceptances), and this trend continues in the first half of 2017. Invented names for centralised medicinal products are reviewed by the Name Review Group (NRG) of the European Medicines Agency (EMA), which meets approximately every Read More

France envisages joining BeNeLuxA initiative

Eveline Van Keymeulen

According to recent statements of the Dutch Minister of Health, the French Minister of Health indicated during the last meeting of the Council of the European Union that France is considering joining the BeNeLuxA initiative, the collaboration between the Belgian, Dutch, Luxembourg and Austrian governments on pharmaceutical policy. If France joins the initiative, the new Read More